Trustee Report 2020 Smithkline Beecham Senior Executive Pension Plan
Summary Pension Trustee Report 2020 SmithKline Beecham Senior Executive Pension Plan For the year ending 31 December 2020 Welcome to your Report Welcome to the Summary Trustee Report for 2020 for the SmithKline Beecham Senior Executive Pension Plan (the ‘Plan’), which provides a summary of the finances, investments and funding of the Plan over the year to 31 December 2020. The Plan is sponsored by GlaxoSmithKline Services Unlimited (‘GSK’). Covid-19 In response to the Coronavirus (Covid-19) pandemic, a Covid-19 working group was formed in March 2020, comprising the Chairs of the Trustee Boards and the various sub-committees. This group continues to meet frequently and monitors the impact of the Covid-19 pandemic on all key areas, including the employer covenant, the ongoing performance of the third party providers (including business continuity), DB funding levels, the investment manager performance, asset custody, liquidity of funds, administrative performance and DC scheme considerations. The Trustee is pleased to report that, to date, the pandemic has had no lasting detrimental impact on any key area for the Schemes. The financial statements reflect fair value of the Fund’s assets at the reporting date. At the year end (i.e. 31 December 2020), and subsequent to the year end, there have been no restrictions imposed on the trading of any assets. Membership The chart below shows the membership of the Plan as at 31 December 2020. Employee members 3 Employee members are current employees who are covered for Death in Service benefits only. Deferred members Plan 82 Deferred members are are former employees who membership have accrued benefits for past service but have not yet retired.
[Show full text]